TSPO and retinal degeneration: Inspired by this endogenous immunomodulatory mechanism, our laboratory tested the ability of a synthetic and highly specific TSPO ligand, XBD173 (AC-5216, emapunil), to influence microglial reactivity in the acute white light-induced retinal degeneration mouse model (Scholz et al., 2015a).